Melatonin, synthesized primarily by the pineal gland, is a neuroendocrine hormone with high membrane permeability. The vascular effects of melatonin, including vasoconstriction and vasodilation, have been demonstrated in numerous studies. However, the mechanisms underlying these effects are not fully understood. Largeconductance Ca 2+ -activated K + (BK Ca ) channels are expressed broadly on smooth muscle cells and play an important role in vascular tone regulation. This study explored the mechanisms of myocyte BK Ca channels and endothelial factors underlying the action of melatonin on the mesenteric arteries (MAs). Vascular contractility and patch-clamp studies were performed on myocytes of MAs from Wistar rats. Melatonin induced significant vasodilation on MAs. In the presence of N ω -nitro-l-arginine methyl ester (l-NAME), a potent endothelial oxide synthase (eNOS) inhibitor, melatonin elicited concentration-dependent relaxation, with lowered pIC 50 . The effect of melatonin was significantly attenuated in the presence of BK Ca channel blocker iberiotoxin or MT1/ MT2 receptor antagonist luzindole in both (+) l-NAME and (−) l-NAME groups. In the (+) l-NAME group, iberiotoxin caused a parallel rightward shift of the melatonin concentration-relaxation curve, with pIC 50 lower than that of luzindole. Both inside-out and cell-attached patch-clamp recordings showed that melatonin significantly increased the open probability, mean open time and voltage sensitivity of BK Ca channels. In a cell-attached patch-clamp configuration, the melatonin-induced enhancement of BK Ca channel activity was significantly suppressed by luzindole. These findings indicate that in addition to the activation of eNOS, melatonin-induced vasorelaxation of MAs is partially attributable to its direct (passing through the cell membrane) and indirect (via MT1/MT2 receptors) activation of the BK Ca channels on mesenteric arterial myocytes.
Introduction
Melatonin (N-acetyl-5-methoxytryptamine) is the primary hormone of the pineal gland, mainly secreted at night (Saarela & Reiter 1994) . Increasing evidence indicates that melatonin plays an important role in regulating cardiovascular homeostasis as well as in the formation and organization of biorhythms (Cook et al. By regulating blood vessel diameter, melatonin affects arterial blood pressure and local blood flow to organs and tissues (Cook et al. 2011 , Pandi-Perumal et al. 2008 .
Melatonin exerts many of its physiological actions through interaction with specific melatonin receptors that are present in mammalian tissues (Pandi-Perumal et al. 2008 , Zlotos et al. 2014 . Three high-affinity melatonin receptor subtypes -MT1, MT2, and MT3 receptorshave been identified and cloned (Nosjean et al. 2000 , Dubocovich et al. 2003 . Melatonin predominantly acts via two G-protein-coupled receptors: MT1 and MT2 (Pandi-Perumal et al. 2008) . The activation of melatonin receptors on endothelial and vascular smooth muscle cells and antioxidant properties of melatonin could be responsible for the melatonin effects on vascular tone (Paulis & Simko 2007) . The effects of melatonin on vascular function are complex; melatonin receptor activation causes vasoconstriction in some vasculatures and vasodilation in others. For instance, melatonin has been found to elicit vasoconstriction in certain arteries (Evans et al. 1992 , Geary et al. 1997 , Ting et al. 1997 , Viswanathan et al. 1997 , such as coronary vessels, the renal vascular bed (Yang et al. 2001 , Cook et al. 2011 , Tunstall et al. 2011 ) and cerebral arteries (Geary et al. 1997 (Geary et al. , 1998 , whereas it induces vasodilation in others (Satake et al. 1991 , Weekley 1991 , Doolen et al. 1998 , such as aorta, pulmonary and umbilical vascular bed, and mesenteric arteries (MAs) (Weekley et al. 1993 , Girouard et al. 2001 , Thakor et al. 2010 . These opposite effects may due to melatonin's binding to 2 different receptors, which are differently distributed on different vascular beds (Doolen et al. 1998) . The activation of MT1 receptors has been widely associated with cAMP decrease and phosphatidylinositol-4,5-bisphosphate hydrolysis, which would lead to the inhibition of vasodilation or vasoconstriction (Paulis & Simko 2007) . The activation of MT2 receptors on endothelial cells (ECs) may involve an increased nitric oxide (NO) production and an endothelium-dependent vasodilation (Anwar et al. 2001 , Paulis & Simko 2007 , Reiter et al. 2009 ).
Both endothelium-dependent and non-endotheliumdependent pathways are involved in melatonin's effects on blood vessels, which mainly occur following activation of MT1 and/or MT2 receptors (Paulis & Simko 2007 , Hung et al. 2013 . In addition to these well-established mechanisms, MT1 receptors have also been reported to couple to large-conductance Ca 2+ -activated K + (BK Ca ) channels (13, 18) and to G protein-activated inward rectifier K + channels (GIRK Kir 3) (Jiang et al. 1995) , which indicates that K + channels on vascular myocytes are potential targets of melatonin. BK Ca channels, activated by both membrane depolarization and intracellular calcium, are broadly expressed on smooth muscle cells (SMCs) and play a critical role in vascular tone regulation (Nelson & Quayle 1995 , Ledoux et al. 2006 , Ko et al. 2008 . There is indirect evidence for the inhibition of BK Ca channels by melatonin in rat cerebral arteries (Geary et al. 1997 (Geary et al. , 1998 .
Previous studies have demonstrated that melatonin has high membrane permeability and displays high lipophilicity (Yu et al. 2016) . Melatonin can enter and leave cells in seconds; the literature therefore suggests that melatonin is secreted by simple diffusion across the pinealocyte plasma membrane (Simonneaux & Ribelayga 2003 , Yu et al. 2016 . Given this background, we wondered whether these small molecules could pass through the cell membrane and act on BK Ca channels directly. To date, no studies have investigated this hypothesis.
In the rat, the mesenteric circulation receives approximately one-fifth of the cardiac output; thus, regulation of this bed makes a significant contribution to the regulation of systemic blood pressure (Nichols et al. 1985) . Previous studies have shown that melatonin induces vasodilation in the MAs (Girouard et al. 2001) . Although endothelium-independent and cycle AMPdependent mechanisms have been suggested, the precise mechanisms by which melatonin affects the vascular tone of the MAs have not been fully determined. Therefore, this study was designed to determine (1) whether melatonin activates BK Ca channels on MA SMCs; (2) whether both direct and indirect activation of BK Ca channels are involved in melatonin-induced vasorelaxation of MAs. The information obtained will expand the knowledge of melatonin's effect on the peripheral resistance arteries and enhance understanding of the potential effects of melatonin on blood pressure regulation in humans.
Materials and methods

Animals
Eight-week-old male Wistar rats weighing 180-220 g were used in these experiments. The animals were housed under controlled conditions with a 12 h light-darkness cycle and ambient temperature of 24°C, with food and water available ad libitum. All experimental procedures and protocols conformed to the recommended guidelines on the care and use of laboratory animals issued by the Chinese Council on Animal Research. The study was approved by the ethical committee of Beijing Sport University.
Immunofluorescence
For immunofluorescence staining, MA sections were fixed with 4% paraformaldehyde in PBS for an hour at room temperature and then permeabilized by 0.2% Triton X-100 for 15 min. After extensive washing with PBS, the tissue sections were blocked for non-specific antibody binding 60 min with 5% BSA, then incubated in a rabbit polyclonal antibody specific for Anti-Melatonin Receptor Type 1 (Alomone Labs, Jerusalem, Israel; 1:200) or AntiMelatonin Receptor Type 2 overnight at 4°C. The second Alexa Fluor 488 Goat Anti-Rabbit IgG antibody (Molecular Probes, 1:1000) was used for 1 h next day after washing. The fluorescence images were captured using a TCS-SP5 confocal laser scanning microscope (Leica). Image analysis software was performed in ImageJ (NIH, version1.46r).
Assessment of vascular function
The animals were euthanized with sodium pentobarbital (100 mg/kg, i.p.). The MA and its branches were removed and placed in cold Krebs solution with a composition of 131.5 mM NaCl, 5 mM KCl, 1.2 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 11.2 mM glucose, 13.5 mM NaHCO 3 , 0.025 mM EDTA (37°C, pH 7.4), and aerated with 95% O 2 and 5% CO 2 . Short segments of A3 were used for contractile studies performed with a multi myograph system (620M, DMT, Denmark) per the procedures in previous studies (Shi et al. 2015) .
For all vessels, we evaluated the contractile response for tension by measuring the maximum peak height and expressing it as the percentage of maximal tension achieved to 60 mM K + (K max ), and calculated pIC 50 (−logIC 50 , the negative logarithm of the half-maximal inhibitory concentration, a measure of the effectiveness of a substance in inhibiting a specific biological or biochemical function). To examine the effect of melatonin on vascular tone, tissues were first contracted with 10 −5 M norepinephrine (NE). Then, responses to the cumulative addition of melatonin (10 −7 -10 −3 M) were tested. In some experiments, non-selective nitric oxide synthase (NOS) inhibitor N ω -nitro-l-arginine methyl ester (l-NAME, 100 μM) was added after K max measurement.
Cell isolation
MAs were removed, cleaned of fat and connective tissue, cut into tissue pieces (0.5-1 mm in both length and width) and placed in digestion buffer (Ca 2+ -free ice-cold physiological salt solution I (PSS I)) containing 137 mM NaCl, 5.6 mM KCl, 1 mM MgCl 2 , 10 mM HEPES and 10 mM glucose (adjusted to 7.4 with NaOH). Dissected segments were incubated for 30 min at 37°C in digestion buffer supplemented with papain (0.3 mg/mL, Worthington Biochemical, USA) and dithiothreitol (1 mg/mL, SigmaAldrich), followed by a second incubation (20 min at 37°C) in digestion buffer supplemented with collagenases Type F (1.5 mg/mL, Sigma) and Type1-S (1 mg/mL, SigmaAldrich). Tissues were then washed 3-4 times with PSS II containing 137 mM NaCl, 5.6 mM KCl, 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, 0.42 mM Na 2 HPO 4 , and 0.44 mM NaH 2 PO 4 (99.9% O 2 for 40 min, adjusted to 7.3-7.4 with NaOH), and triturated gently using a firepolished pipette to create a cell suspension.
Electrophysiological recording techniques
Standard patch-clamp recording techniques were used to measure currents in the cell-attached or inside-out patch configuration (Hamill et al. 1981) . Currents were amplified using an Axon700B amplifier, sampled at 10 KHz and filtered at 2 KHz with an 8-pole Bessel filter.
Conventional whole-cell recording Whole-cell K + currents were measured with conventional voltageclamp configuration. The cell bath solution comprised the following (mM): 134 NaCl, 6 KCl, 1 MgCl 2 , 1.8 CaCl 2 , 10 glucose and 10 HEPES (pH 7.4 with KOH). The pipette solution contained the following (mM): 110 K-Asp, 30 KCl, 1 EGTA, 3 Na 2 ATP, 0.85 CaCl 2 , 10 glucose and 10 HEPES (pH 7.2 with KOH). Outward K + currents were elicited by a series of 400 ms depolarizing voltage steps. To measure current (I)-voltage (V) relationships, cells were held at −60 mV and then stepped to test potentials from −60 to +80 mV in 10 mV increments for 400 ms at each potential. To assess BK Ca and voltage-dependent potassium channel (K V ) current amplitudes, outward K + currents were elicited in the absence and presence of 100 nM iberiotoxin (IbTX) or 3 mM 4-aminopyridine (4-AP).
Single-channel recording The pipette resistance ranged from 10 to 15 MΩ in the cell-attached and insideout patch experiments. Recording pipette electrodes were fabricated from disposable micro-pipettes (BF150-86-10, Sutter Instrument, USA; ID: 0.86 mm, OD: 1.50 mm) in 2 stages on a vertical electrode puller (PC10, Narishige, Japan) to give resistances of 10-15 MΩ when filled with solution. The bath solution (PSS) and the pipette solution were identical and contained 45 mM KCl, 100 mM K-Asp, 1 mM EGTA, 10 mM HEPES and 5 mM glucose, adjusted to pH 7.4 with KOH. Pipettes were filled with 100 mM KCl, 45 mM K-Asp, 1 mM EGTA, 10 mM HEPES and 5 mM glucose, adjusted to pH 7.4 with KOH. As previously described (Shi et al. 2013) , Ca 2+ (CaCl 2 ) was added to achieve the desired level of free Ca 2+ (determined using WinMAXC software; Chris Patton, Stanford University).
For single BK Ca channel recording, as an index of channel steady-state activity, we used the product of the number of channels in the patch (N) and the channel open probability (Po). The number of BK Ca was estimated from the maximum observed current level at relatively high voltage and/or bath Ca 2+ concentration. The Po, amplitude and kinetic characteristics of the channels were analyzed with pCLAMP software (Clampfit 10.2); only recordings with stable Po values for a minimum of 2 min were analyzed.
Voltage-dependent behavior of the channel Po was modeled with the Boltzmann function:
where V 1/2 is the membrane potential for the half-maximal channel activation. The Ca 2+ -dependent activation was fitted with the Hill equation:
where η H is the Hill coefficient, and K d is the dissociation constant.
Chemicals and statistics
All chemicals were purchased from Sigma-Aldrich unless otherwise stated. Statistical analysis was conducted using either one-way analysis of variance (ANOVA) followed by a Tukey's post hoc test for multiple comparisons or a paired Student's t-test; values of P < 0.05 were considered significant. Data are expressed as mean ± s.d.; n refers to the number of animals studied. Concentration-response curves were analyzed by computer-assisted nonlinear regression to fit the data using GraphPad Prism (GraphPad Software) to obtain −logIC 50 (pIC 50 ). Melatonin is first dissolved in dimethyl sulfoxide (DMSO). The final concentration of DMSO was less than 0.1% that had no effects on currents.
Results
MT1 and MT2 receptor expression in MAs
Using immunofluorescence and confocal imaging, we examined the distribution of MT1 and MT2 receptors in MAs. As shown in Fig. 1A , MT1 and MT2 receptors were detected in both endothelium and VSMCs.
Melatonin-induced vasodilation of MAs
In each MA ring, a high dose of potassium (60 mM KCl) was first applied to induce the maximal contraction (100% K max ). Then, 2 sets of experiments with or without l-NAME (100 μM) treatment were conducted in separate artery rings. In the absence of l-NAME (Fig. 1B) , norepinephrine (NE, 10 −5 M) induced a significant increase of vascular tone, 160.5 ± 7.6% K max (n = 8). At the plateau of NE-induced contraction, melatonin (10 −7 -10 −3 M) was administered in half-log increments. As shown in Fig. 1B and E, melatonin induced dose-dependent vascular relaxation in MAs. Here, 10 −5 M NE-induced maximal tension increase was treated as 100%. The pIC 50 value (negative logarithm of the molar concentration required to block the NE-induced contraction by 50%) in the melatonin-treated group was 4.75 ± 0.11 (n = 8, Fig. 1E ). In the presence of l-NAME (Fig. 1C) , the maximal NE-induced force was 182.8 ± 9.2% K max (n = 8), which was higher than that in the absence of l-NAME (160.5 ± 7.6% K max , P < 0.01). Notably, l-NAME by itself had no effect on basal tone, but it did significantly increase contractile responses to NE. In the presence of l-NAME (Fig. 1F) , melatonin also elicited a concentrationdependent relaxation with pIC 50 = 3.93 ± 0.12 (n = 8, P < 0.01, vs (−) l-NAME). These results suggest that melatonin-induced vasorelaxation is partially due to the activation of eNOS.
In order to examine the role of the BK Ca channel in melatonin-induced vascular relaxation, iberiotoxin (IbTX, a specific BK Ca channel blocker, 10 −8 M) was added to the bath to incubate the MA rings. In both l-NAME-treated and untreated groups, 10 −8 M IbTX did not change the resting tension (Fig. 1C) . However, after 2-min incubation with IbTX, a parallel rightward shift of the melatonin concentration-relaxation curve was detected in both l-NAME-treated and untreated groups, compared to those without IbTX incubation (Fig. 1B , C, E and F). The pIC 50 was 4.11 ± 0.09 in the (−) l-NAME + IbTX group, which was lower than that in the group without IbTX treatment ((−) l-NAME: pIC 50 = 4.75 ± 0.11, both n = 8, P < 0.01). The pIC 50 was 2.74 ± 0.13 in the (+) l-NAME + IbTX group, which was also lower than that in the group without IbTX treatment ((+) l-NAME: pIC 50 = 3.93 ± 0.12, P < 0.01, n = 8 in each group). It should be noted that following IbTX incubation, the melatonin concentration-relaxation curve was markedly rightward-shifted in the (+) l-NAME group (pIC 50 = 2.74 ± 0.13) compared to that of the Research t zhao and others Melatonin activates BK Ca directly and indirectly non-l-NAME-treated group (pIC 50 = 4.11 ± 0.09). These results indicate that in addition to the activation of eNOS, melatonin-induced vasorelaxation is partially attributable to its activation of the BK Ca channels on vascular smooth muscle cells (VSMCs).
To determine whether the vasorelaxation induced by melatonin in MAs occurred through MT receptors, luzindole (MT1 and MT2 receptor blocker) was applied to the preparations before NE. As shown in Fig. 1B and C, in both the L-NAME-treated and untreated groups, 2 × 10 −6 M luzindole did not change the resting tension. However, after 2-min incubation with luzindole, a parallel rightward shift of the melatonin concentration-relaxation curve was detected in both the l-NAME-treated and untreated groups, compared to those without luzindole incubation ( Fig. 1E and F). The pIC 50 was 3.55 ± 0.10 in the (−) l-NAME + Luz group, which was lower than that in the group without luzindole treatment ((−) l-NAME: pIC 50 = 4.75 ± 0.11, both n = 8, P < 0.01). The pIC 50 was 3.36 ± 0.12 in the (+) l-NAME + Luz group, which was also lower than that in the group without luzindole treatment ((+) l-NAME: pIC 50 = 3.93 ± 0.12, P < 0.01, n = 8 in each group). These results indicate that melatonin-induced vasorelaxation may operate partially through the binding of melatonin to MT receptors. Unlike with IbTX, following luzindole incubation, the melatonin concentration-relaxation curve was not significantly shifted in the (+) l-NAME group (pIC 50 = 3.36 ± 0.12) compared to that of the nonl-NAME-treated group (pIC 50 = 3.55 ± 0.10). These results indicate that in melatonin-induced vasorelaxation, the eNOS-dependent part occurs through MT receptors. Therefore, if the MT receptors are blocked by luzindole, there is no significant difference between the (+) l-NAME and (−) l-NAME groups. Iberiotoxin when combined with luzindole provided an additional inhibition of relaxation as compared to luzindole alone in either (−) l-NAME or (+) l-NAME group (Fig. 1B, C, E and F). Another implication of the results is that melatonin-induced partial vasorelaxation, which depends on myocyte BK Ca channel activation, involves both MT receptor-mediated and non-MT receptormediated mechanisms.
Since endothelium-dependent component in the vascular bed also includes NO-independent endotheliumderived hyperpolarizing factor (EDHF) mechanism, the vasorelaxation effect of melatonin was also investigated on de-endothelized MAs. As shown in Fig. 1D and G, the vasodilation induced by melatonin was not significantly different from that in (+) l-NAME group, which indicates that EDHF mechanisms may not be involved in melatonininduced vasorelaxation of MAs.
Melatonin increases whole-cell BK Ca currents in MA SMCs
To compensate for differences in cell size, membrane I K is expressed relative to cell capacitance (pA/pF). To assess the effects of melatonin on BK Ca or K V components, the selective BK Ca channel inhibitor IbTX (100 nM) or selective K V channel inhibitor 4-AP (3 mM) was applied first to the cells, and then melatonin (10 and 100 μM) was applied in the presence of IbTX or 4-AP (Fig. 2) . As shown in Fig. 2A , B, C and D, either 4-AP or IbTX suppressed the currents. At the holding potential (HP) of +80 mV, the currents were inhibited by 4-AP to 72.05 ± 5.60% of control and by IbTX to 27.60 ± 2.90% of control, respectively (n = 12 cells/6 rats), indicating that the outward K + currents consisted of at least two components: 4-AP-sensitive (K V ) and IbTXsensitive ones (BK Ca ). After 4-AP incubation, the outward K + current density was significantly inhibited, and the following melatonin increased the left parts (mainly BK Ca currents) significantly in a dose-dependent manner. At an HP of +80 mV, the peak BK Ca current density was increased from 20.99 ± 2.20 pA/pF to 32.08 ± 3.10 pA/pF and 46.17 ± 3.80 pA/pF after 10 μM and 100 μM melatonin treatment (each n = 12 cells/6 rats, both P < 0.01), respectively ( Fig. 2A and B) . As shown in Fig. 2C and D, after IbTX pretreatment, the whole-cell I K was markedly inhibited. The inhibited parts are IbTX-sensitive currents (BK Ca ), and the left parts are mainly K V currents. However, the melatonin applied after IbTX pretreatment had no significant change on K V currents. These data indicate that melatonin activates BKCa channels but not KV channels.
To examine whether the activation of BK Ca channels is through MT1/MT2 receptors, luzindole (2 × 10 −6 M) was applied before melatonin. As shown in Fig. 2E and F, luzindole had no significant change on BK Ca currents. At HP = +80 mV, after luzindole treatment, the peak BK Ca current density was increased from 20.64 ± 2.13 pA/pF to 36.37 ± 3.51 pA/pF by 100 μM melatonin. The increase by melatonin was significantly inhibited by luzindole compared to that of control (from 22.65 ± 2.40 pA/pF to 44.64 ± 3.50 pA/pF by 100 μM melatonin, each n = 6, P < 0.01), suggesting that the activation of BK Ca currents by melatonin was mediated by MT1/MT2 receptors. 
Activation of BK Ca channel in MA SMC by melatonin in cell-attached patches
Using cell-attached patch-clamp recording (Fig. 3A) , we examined the effect of melatonin on BK Ca channel activity and gating properties. Figure 3B shows representative records of single BK Ca channels under cellattached configuration with symmetrical 145 mM K + at a HP of +40 mV ([Ca 2+ ] free = 0.1 μM). Po increased along with membrane potential (data not shown). A linear fit revealed an average single-channel conductance (G) of 270.8 ± 24.5 pS (n = 8). Melatonin (100 and 300 μM) had no significant impact on the channel conductance (Fig. 3C) . Melatonin significantly increased the Po of BK Ca channels in a concentration-dependent manner. For example, with 100 μM melatonin treatment, the Po (0.025 ± 0.003, n = 8) was significantly increased compared with that of the control (0.002 ± 0.002, n = 8, P < 0.01), whereas 300 μM melatonin increased the Po to 0.040 ± 0.005 (n = 8). To examine whether the activation of BK Ca channels occurred through MT1/MT2 receptors, luzindole (2 × 10 −6 M) was applied before melatonin. Luzindole significantly inhibited the increase of Po of BK Ca channels induced by melatonin (100 μM melatonin: Po = 0.009 ± 0.001; 300 μM melatonin: Po = 0.030 ± 0.001; both n = 8, P < 0.01 vs control). Luzindole itself had no significant impact on the activity of BK Ca channels; however, it could markedly inhibit the Po increase induced by melatonin. The conductance of BK Ca was unaffected by luzindole.
We further examined the effects of melatonin on the gating properties of the BK Ca channels in cell-attached patch configuration (n = 8 in each group). At the testing potential of +40 mV, the Po was significantly increased in the melatonin treatment group (Fig. 3B and C) . The mean open time (To) of a single BK Ca channel was increased in the 100 μM melatonin treatment group (10.80 ± 1.20 ms) compared with the control group (7.54 ± 0.85 ms), but not significantly changed in the 300 μM melatonin treatment group (9.70 ± 1.90 ms). The mean close time (Tc) was significantly decreased in both the 100 and 300 μM melatonin treatment groups (411.60 ± 34.50 ms and 337.90 ± 21.30 ms, respectively) compared with the control group (3531.95 ± 350.60 ms, n = 8 in each group). These data show that luzindole inhibits Po increase mainly by prolonging the closed state of BK Ca channels.
Activation of BK Ca channel by melatonin in inside-out patches
We also examined the effect of melatonin on BK Ca channel activity and gating properties in an inside-out patch-clamp configuration (Fig. 4) . Since the BK Ca activation induced by melatonin is much stronger in an inside-out patchclamp configuration than in a cell-attached configuration, lower concentrations of melatonin (10, 30, 100 μM) were used here. Figure 4A shows representative records of single BK Ca channels in an inside-out configuration at different voltages with symmetrical 145 mM K + in the presence of 0.1 μM and 1μM Ca 2+ with or without melatonin (0, 10, 30, 100 μM). A linear fit revealed an average single-channel conductance (G) of 279.3 ± 45.0 pS ([Ca 2+ ] free = 0.1 μM, n = 8) and 305.5 ± 48.0 pS ([Ca 2+ ] free = 1 μM, n = 8), respectively. Melatonin (10, 30, 100 μM) had no significant effect on the channel conductance (Fig. 4B) .
We further examined the effects of melatonin at different doses on the gating properties of the BK Ca channels (Fig. 4B , n = 8 in each group). At the testing potential of +40 mV, the Po was significantly increased by melatonin in a concentration-dependent manner. When the [Ca 2+ ] free = 0.1 μM, the mean open time (To) of a single BK Ca channel was longer in the melatonin group than in the control group (7.77 ± 0.80 ms (10 μM melatonin), 9.92 ± 1.20 ms (30 μM), 16.44 ± 1.82 ms (100 μM) vs 4.96 ± 0.40 ms (control); all P < 0.01). The Tc was shorter in the melatonin group than in the control group (208.10 ± 21.20 ms (10 μM melatonin), 155.80 ± 25.60 ms (30 μM), 51.46 ± 6.70 ms (100 μM) vs 251.20 ± 19.60 ms (control), all P < 0.01). In summary, melatonin treatment decreases Tc and increases To in a dose-dependent manner. When the [Ca 2+ ] free = 1 μM, melatonin treatment also decreases Tc and increases To, which is most prominent in 100 μM melatonin.
The influence of melatonin on the voltage and calcium dependence of the BK Ca channels was also examined (Fig. 5) . Notably, Po increased along with membrane potential (Fig. 5A) . The NPo was normalized to the max probability. The Po-voltage relationships were fitted with the Boltzmann distribution to determine the voltage for half activation of the channel, V 1/2 (equation described in 'Materials and methods' section). As can be seen from Fig. 5B , V 1/2 was shifted from 54.78 ± 0.56 mV (control) to 44.47 ± 0.52 mV by 10 μM melatonin, and to 30.44 ± 0.48 mV by 100 μM melatonin (0.1 μM [Ca 2+ ] free ). However, melatonin had no significant effect on the slope.
A similar leftward shift in Ca 2+ -dependent activation was observed with melatonin treatment. Figure 5C plots the relations of NPo normalized to their maximum value against [Ca 2+ ] free . The Po-Ca 2+ curve fitted (using least squares) by Hill equation with a K d value of 1.90 ± 0.10 (control), 1.35 ± 0.11 (10 μM Melatonin) and 0.32 ± 0.02 (100 μM Melatonin, n = 6 in each group), respectively. The Hill coefficient (H) was 1.67 ± 0.12 (control), 1.57 ± 0.17 (10 μM Melatonin) and 1.25 ± 0.11 (100 μM Melatonin).
To rule out the direct effect of luzindole on single BK Ca channels, we examined the effects of luzindole on single BK Ca channels in inside-out configuration ( Fig. 5D and E). Luzindole (2 × 10 −6 M) itself had no effect on single BK Ca activity in inside-out configuration. After luzindole pretreatment, the Po increase induced by melatonin (100 μM) was not significantly changed.
Discussion
The results of this study demonstrate that (1) melatonin induces concentration-dependent vasodilation in MAs; (2) in addition to activating eNOS, melatonin significantly activates BK Ca channels on the mesenteric arterial SMCs; (3) this enhancement of BK Ca channel activity involves both direct and indirect (MT1/MT2 receptor-mediated) pathways. Thus, in MAs, vasodilation by melatonin depends on the activity of both endothelial factors and BK Ca channels. These findings suggest a novel but important pathway of melatonin in regulating vascular tone: passing through the cell membrane and activating the BK Ca channel directly.
Increasing evidence shows that melatonin exerts many of its physiological actions through interaction with MT1 and MT2 receptors, which belong to the G-protein-coupled family of membrane receptors (PandiPerumal et al. 2008 , Tunstall et al. 2011 . The different vascular effects observed with melatonin are attributed to the relative distribution of MT1 and MT2 receptors, since MT1 receptor activation causes vasoconstriction and MT2 receptor activation causes vasodilation (Doolen et al. 1998) .
ENOS is primarily responsible for the generation of NO in the vascular endothelium (Fish et al. 2006) . NO produced by eNOS in the vascular endothelium plays crucial roles in regulating vascular tone (Förstermann & Münzel 2006) . Hence, a functional eNOS is essential for a healthy cardiovascular system. Once produced in ECs, NO diffuses across the VSMC membranes and activates the enzyme-soluble guanylate cyclase (sGC), which catalyzes the conversion of guanosine triphosphate into cyclic guanosine monophosphate (cGMP) (Denninger & Marletta 1999) . CGMP, in turn, activates protein kinase G (PKG), which promotes multiple phosphorylation of cellular targets, lowering cellular Ca 2+ concentrations and promoting vascular relaxation (Cornwell et al. 1994) . In this study, melatonin-induced vasodilation was significantly inhibited in the presence of l-NAME (eNOS inhibitor). Thus, vasodilation depends on the presence of NO released by the endothelium. This finding suggests that the endothelium (endotheliaderived NO) is a target for melatonin action. Melatonin increases NO availability (Paulis & Simko 2007) to induce vasodilation, which is consistent with previous studies (Girouard et al. 2001) .
In another experiment, we found that pretreatment of the MAs with luzindole (MT1/MT2 receptor inhibitor) also significantly inhibited melatonininduced vasorelaxation. This finding suggests that melatonin may act partially through MT receptors. However, the melatonin concentration-relaxation curve was not significantly shifted in the (+) l-NAME group (pIC 50 = 3.36 ± 0.12) compared with the non-l-NAMEtreated group (pIC 50 = 3.55 ± 0.10). These results suggest that in melatonin-induced vasorelaxation, the eNOSdependent part occurs mainly through MT receptors. Therefore, if the MT receptors are blocked by luzindole, there is no significant difference in pIC 50 between the (+) l-NAME and (−) l-NAME groups.
In addition to the endothelium, BK Ca channels on VSMCs also play an important role in vessel tone regulation (Bukiya et al. 2007) . BK Ca channels are mainly activated and hyperpolarize the membrane, which, in turn, suppresses the activity of the voltage-gated Ca 2+ channels and thereby relaxes the artery (Nelson & Quayle 1995 , Davis & Hill 1999 . In the present study, IbTX caused a parallel rightward shift of the melatonin concentrationrelaxation curve in both l-NAME-treated and untreated groups, which indicates that in addition to the activation of eNOS, melatonin-induced vasorelaxation is partially attributable to its activation of the BK Ca channels on VSMCs. Another interesting thing to be noted is that the NO-dependent component of relaxation appears sensitive to iberiotoxin too (Fig. 1) . As reported, BK Ca channels are also detected in ECs in rat MAs, and the activation of BK Ca channels on ECs also induces vasodilation (JacksonWeaver et al. 2013) . This may partially explain the sensitivity of NO-dependent component to iberiotoxin in the present study. Then, whether melatonin's action on BK Ca channels in VSMCs was receptor mediated or non-receptor mediated was still unclear. We found that in the presence of l-NAME, luzindole (2 × 10 −6 M) had no significant effect on MAs, but suppressed the vasodilation induced by melatonin. If melatonin-induced BK Ca activation were all through MT1/MT2 receptors, then luzindole should abolish the vasodilation of melatonin in the presence of l-NAME. However, this was not the case. The melatonin concentration-relaxation curve was only rightshifted in the luzindole-treated group (pIC 50 = 3.36 ± 0.12) compared with the control group (pIC 50 = 3.93 ± 0.12). This finding indicates that melatonin-induced vasorelaxation dependent on myocyte BK Ca channel activation involves not only MT receptor-mediated mechanisms, but also non-MT receptor-mediated mechanisms.
Previous studies have demonstrated that melatonin constricts cerebral arteries (Geary et al. 1997) in vitro, following G protein-dependent inhibition of Ca 2+ -activated BK Ca channels. By using an open-skull preparation in anesthetized rats, Régrigny also showed that melatonin directly constricts small-diameter cerebral arterioles in rats (Régrigny et al. 1999) . This vasoconstriction effect is mediated by the inhibition of BK Ca channels following activation of MT1 and/or MT2 receptors. Our results were not consistent with those findings. If melatonin inhibits BK Ca channels on mesenteric arterial myocytes, then melatonin should induce vasoconstriction. However, we found just the opposite effect: melatonin induced vasodilation in MAs. IbTX pretreatment significantly inhibited the melatonin-induced relaxation. These data suggest that melatonin activates, rather than inhibits, BK Ca channels on mesenteric arterial myocytes.
The mechanisms underlying melatonin-induced activation of BK Ca channels in MA myocytes were further studied using electrophysiological studies. Whole-cell recording showed that melatonin significantly increased BK Ca currents but not K V currents. In previous studies, both activation and inactivation of potassium channels by melatonin have been reported. For example, it was found that 2-indomelatonin (a melatonin receptor agonist) increased BK Ca channel activity in nonpregnant and pregnant rat uterine myocytes in the cell-attached patch-clamp configuration (Steffens et al. 2003) . However, the effect on NPo was transient; 2 min after the addition of 2-iodomelatonin, the open probability had returned to the basal value. However, in this study, we found that melatonin had a sustained, concentration-dependent activating effect on BK Ca channels. A cell-attached patch clamp showed that melatonin significantly activated BK Ca channels. Blocking MT1/MT2 receptors by luzindole significantly inhibited the NPo increase, which suggests that melatonin acts at least partially by binding to MT receptors. Our vascular contraction experiments supported this theory: MT receptor blocker inhibited melatonin-induced vasorelaxation.
Melatonin is a highly permeant neutral molecule that can pass through the cell membrane rapidly. Due to its highly lipophilic nature, melatonin passes through cell membranes with ease (Yu et al. 2016) . We speculated that melatonin could act on BK Ca channels directly. To evaluate this hypothesis, an inside-out patch clamp was conducted. The results clearly showed that melatonin could activate BK Ca channels directly. Our vessel contractility experiments with luzindole also lent strong support to this hypothesis. In the presence of L-NAME, both luzindole and IbTX pretreatment caused a parallel rightward shift of the melatonin concentration-relaxation curve (Luzindole: pIC 50 = 3.36 ± 0.12; IbTX: pIC 50 = 2.74 ± 0.13) compared with the control group (pIC 50 = 3.93 ± 0.12). IbTX shifted the curve more than luzindole, which suggests that melatonin-induced activation of BK Ca channels occurs not only through binding to MT receptors but also through other means (non-receptor-mediated pathway). One possibility is that melatonin activates the BK Ca channel directly, just as our inside-out patch-clamp study demonstrated. In both the cell-attached and inside-out patch-clamp configuration, melatonin displayed an alteration of the gating properties on BK Ca channels by prolonging the time in the open state (To) and shortening the time in the closed state (Tc). In inside-out patch-clamp configuration, luzindole itself had no effect on single BK Ca activity. Moreover, luzindole pretreatment did not change A model for a mechanistic explanation of vasodilation of melatonin on MAs. Both endothelium-dependent and non-endotheliumdependent pathways are involved in melatonininduced vasodilation of MAs. In the endothelium-dependent pathway, by binding to MT1/MT2 receptors, melatonin enhances eNOS to reduce NO production, which induces partial vasodilation. In the non-endothelium-dependent pathway, melatonin causes vasodilation by activating BK Ca channels on VSMCs either directly or indirectly (via MT1/MT2 receptors).
the Po increase induced by melatonin, which can rule out the possibility that MT1/2 receptors are physically associated with BK Ca channel similar to thromboxane receptor and other channels (Li et al. 2010) . However, it is still difficult to determine whether such a compound acts inside or outside of the cell. Usually, a highly permeant compound is observed on both sides of the membrane at almost equal concentrations, whether it is applied inside the cell or outside the cell (Yu et al. 2016) .
Based on these findings, we propose a model for a mechanistic explanation of the vasodilation of melatonin on MAs (Fig. 6) . First, in addition to the enhancement of eNOS on the endothelium, melatonin activates BK Ca channels on mesenteric arterial SMCs to induce vasodilation. Second, the activation of BK Ca channels by melatonin involves direct (non-receptormediated) and indirect (receptor-mediated) mechanisms. Melatonin can pass through the cell membrane with ease and provides on-site activation of BK Ca channels. As an inexpensive and well-tolerated drug, melatonin may be a new therapeutic option for cardiovascular diseases such as hypertension.
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